# Governing AI risk in claims, labels and consumer-facing content
A snack brand's marketing team used a generative AI tool to draft new packaging copy. The AI suggested the phrase "clinically proven to boost immunity" for a fruit snack with added vitamin C. Nobody on the team had run a clinical trial. The copy went through design approval, got printed on thousands of units, and shipped. Within weeks, a regulator flagged it as an unsubstantiated health claim. The recall, relabeling, and reputational cleanup cost far more than the campaign's entire production budget.
This is not a hypothetical edge case. It is the predictable failure mode of using generative AI for claims and labels without governance. This lesson builds the checklist that prevents it.
Fast-moving consumer goods (FMCG) companies ship enormous volumes of consumer-facing text: package copy, nutrition claims, allergen statements, marketing emails, social captions, ingredient descriptions. Generative AI (large language models, or LLMs, that produce human-like text on demand) is attractive here because it speeds up drafting at scale across hundreds of SKUs (stock keeping units, the individual product-variant codes a retailer tracks) and dozens of markets.
But three features of this content make it dangerous territory for unsupervised AI:
It is regulated speech, not just marketing copy. Health and nutrition claims are governed by specific legal regimes, not general advertising standards.
It is printed and distributed at scale before anyone can easily intervene. Unlike a website, you cannot "un-publish" a printed carton once it is on a truck.
LLMs are fluent, not factual.
In the United States, the Food and Drug Administration (FDA) regulates food labeling and health claims under the Food, Drug, and Cosmetic Act, and the Federal Trade Commission (FTC) polices deceptive advertising claims more broadly. The FDA maintains a specific, narrow list of approved health claims (for example, calcium and osteoporosis risk); anything outside that list needs careful qualification or it risks being deemed a misbranded product. See the FDA's guidance on food labeling and claims for the authoritative source.
In the European Union, the Nutrition and Health Claims Regulation (EC) 1924/2006 requires that any health or nutrition claim be pre-authorized and listed in the EU Register of nutrition and health claims, maintained by the European Food Safety Authority (EFSA). Unauthorized claims like "boosts immunity" without a registered, specific basis are enforcement targets across EU member states.
Both regimes share a core principle: the burden of proof sits with the brand, not the regulator. If your AI tool writes it and your team publishes it, your company owns the liability, not the AI vendor.
Good fit:
Poor fit without heavy guardrails:
The pattern: AI is strong at *variation and translation of vetted content*, weak at *originating regulated factual claims*.
A usable checklist has to mapmapUsing software to automate repetitive marketing tasks and campaigns, enabling personalisation at scale across channels like email, web, and social.View full definition → to where failures actually occur: model input, model output, and organizational process.
1. Source-of-truth control
Does the AI tool draw only from an approved, curated database of claims and product facts, or does it freely generate from general training data? Tools built on retrieval-augmented generation (RAG, a technique where the model is restricted to pulling facts from a specific approved document set rather than its general knowledge) are meaningfully safer for claims work than an open general-purpose chatbot.
2. Claim provenance tagging
Every AI-suggested claim should be tagged with its source: is it from the EFSA register, an FDA-approved list, or the model's own generation? If provenance cannot be shown, treat the claim as unverified.
3. Human-in-the-loop sign-off gates
Legal or regulatory affairs review is mandatory before any AI-drafted claim moves to design or print, no exceptions for "minor" copy changes. Minor changes ("boosts" versus "supports") can shift legal meaning entirely.
4. Version and audit trail
Keep a log of which AI tool, version, and prompt generated which piece of copy, and who approved it. Regulators and internal audit will ask "how did this get approved" after any incident; you need an answer.
5. Red-team testing before rollout
Before deploying a tool company-wide, deliberately prompt it with edge cases: "write an aggressive health claim for this snack," "compare this product favorably to a named competitor." If it complies too readily, it needs stricter guardrails or a different tool.
6. Market-specific configuration
A claim compliant in the US may be non-compliant in the EU or UK (which has its own post-Brexit regime via the Food Standards Agency). AI tools must be configured per market, not globally.
7. Allergen and safety statement exclusion
These should never be AI-generated from scratch. Treat them as fixed, legally-sourced fields pulled from verified product databases, not creative text.
# Simplified pseudocode for a claim-check gate in a content pipeline
def check_claim(draft_text, market, claims_db):
matched = claims_db.lookup(draft_text, market)
if not matched:
return "BLOCK: unverified claim, route to legal review"
if matched.status != "approved_for_market":
return "BLOCK: claim not approved in this market"
return "PASS: log claim_id, source, approver, timestamp"This is illustrative, not production code, but it captures the principle: claims should hit a database check, not just a fluency check.
Knowledge check
1. Why did the generative AI tool produce the unsubstantiated claim 'clinically proven to boost immunity' for the fruit snack?
2. What is the key distinction that makes health and nutrition claims a different risk category than general marketing copy?
3. A packaging team wants to use generative AI to speed up drafting ingredient descriptions across 300 SKUs in multiple markets. Based on the lesson, what is the most appropriate governance approach?
4. Select ALL correct answers describing why FMCG labeling is uniquely high-risk territory for unsupervised generative AI use.
Select all the correct answers.
5. Select ALL correct answers that reflect an accurate understanding of 'hallucination' as used in this lesson.
Select all the correct answers.
When an AI vendor pitches a "content generation for FMCG" tool, ask:
Treat vague answers as a red flag. A vendor that cannot describe its guardrail architecture is not ready for regulated content.
🎬 [VIDEO: "How the FDA Regulates Food Labels" - youtube.com/@usfoodanddrugadmin - an FDA overview of the label review process, useful context for where AI-drafted content must plug into human regulatory review]